We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-1.06%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$481B
AUM Growth
+$34.6B
Cap. Flow
+$38.1B
Cap. Flow %
7.92%
Top 10 Hldgs %
29.35%
Holding
15,428
New
1,884
Increased
5,796
Reduced
5,769
Closed
1,724

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.26B
2
MSFT icon
Microsoft
MSFT
+$633M
3
BABA icon
Alibaba
BABA
+$501M
4
ATVI
Activision Blizzard
ATVI
+$484M
5
AAPL icon
Apple
AAPL
+$456M

Sector Composition

Rank Sector Weight
1 Technology 3.03%
2 Consumer Discretionary 2.25%
3 Healthcare 2.2%
4 Financials 2.18%
5 Industrials 1.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NXU.U
12476
DELISTED
Novus Capital Corporation II Units, each consisting of one share of Class A common stock and one thi
NXU.U
$127K ﹤0.01%
12,364
-482,744
-98% -$4.87M
DCRNU
12477
DELISTED
Decarbonization Plus Acquisition Corporation II Unit
DCRNU
$127K ﹤0.01%
+12,334
New +$127K
BSN.U
12478
DELISTED
Broadstone Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of on
BSN.U
$127K ﹤0.01%
12,110
-845
-7% -$8.79K
SWBK.U
12479
DELISTED
Switchback II Corporation Units, each consisting of one Class A ordinary share and one fifth of one
SWBK.U
$127K ﹤0.01%
12,496
+342
+3% +$3.48K
GTE icon
12480
PUT
Gran Tierra Energy
GTE
$265M
$126K ﹤0.01%
17,060
-950
-5% -$5.73K
UBX
12481
PUT
DELISTED
Unity Biotechnology
UBX
$126K ﹤0.01%
4,190
-1,040
-20% -$36.7K
TTOO
12482
CALL
DELISTED
T2 Biosystems, Inc
TTOO
$126K ﹤0.01%
28
-3
-10% -$15.1K
LDHAU
12483
DELISTED
LDH Growth Corp I Units
LDHAU
$126K ﹤0.01%
12,815
-100,909
-89% -$1M
SMED
12484
PUT
DELISTED
Sharps Compliance Corp
SMED
$126K ﹤0.01%
15,200
+100
+0.7% +$930
GTYH
12485
DELISTED
GTY Technology Holdings, Inc. Common Stock
GTYH
$126K ﹤0.01%
16,801
-6,929
-29% -$49.7K
STEX
12486
Streamex Corp
STEX
$74M
$125K ﹤0.01%
+4,191
New +$136K
DHC
12487
CALL
Diversified Healthcare Trust
DHC
$2.15B
$125K ﹤0.01%
36,800
+21,700
+144% +$81.8K
SY
12488
CALL
So-Young International
SY
$185M
$125K ﹤0.01%
29,400
+2,500
+9% +$16.2K
VRNA
12489
DELISTED
Verona Pharma
VRNA
$125K ﹤0.01%
+22,870
New +$133K
GENE
12490
DELISTED
Genetic Technologies Ltd.
GENE
$125K ﹤0.01%
8,094
+2,724
+51% +$46.7K
VHAQ
12491
DELISTED
Viveon Health Acquisition Corp.
VHAQ
$125K ﹤0.01%
+12,492
New +$124K
DOMA
12492
PUT
DELISTED
Doma Holdings, Inc.
DOMA
$125K ﹤0.01%
+676
New +$142K
LHDX
12493
CALL
DELISTED
Lucira Health, Inc. Common Stock
LHDX
$125K ﹤0.01%
+16,500
New +$139K
ACII.U
12494
DELISTED
Atlas Crest Investment Corp. II Units, each consisting of one Class A common stock, $.0001 par value, and one-fourth of one redeemable warrant
ACII.U
$125K ﹤0.01%
12,526
-322,442
-96% -$3.22M
TINV.U
12495
DELISTED
Tiga Acquisition Corp. Units, each consisting of one Class A ordinary share and one half of one warrant
TINV.U
$125K ﹤0.01%
12,012
-506
-4% -$5.29K
ATRS
12496
PUT
DELISTED
Antares Pharma, Inc.
ATRS
$125K ﹤0.01%
34,400
-21,000
-38% -$84.9K
CO
12497
DELISTED
Global Cord Blood Corporation
CO
$125K ﹤0.01%
26,790
-9,804
-27% -$48.1K
RNWK
12498
PUT
DELISTED
RealNetworks Inc
RNWK
$125K ﹤0.01%
78,700
-13,400
-15% -$24.6K
ARAY icon
12499
Accuray
ARAY
$32M
$124K ﹤0.01%
31,358
-62,506
-67% -$248K
ATEC icon
12500
PUT
Alphatec Holdings
ATEC
$1.46B
$124K ﹤0.01%
10,200
-15,500
-60% -$216K

Similar funds

Citadel Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, Citadel Advisors held 15,428 positions worth $481B, up 7.8% from $447B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Citadel Advisors deployed $38.1B of net new capital in Q3 2021, opening 1,884 new positions and adding to 5,796 existing holdings. Its largest new stake was Etsy: 948,509 shares worth $197M.

By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $622M trimmed.

  • Citadel Advisors's largest Q3 2021 buy was Etsy: 948,509 shares worth $197M.
  • Citadel Advisors added most to Tesla in Q3 2021, an estimated $1.26B increase.
  • Citadel Advisors's biggest Q3 2021 reduction was Meta Platforms (Facebook), cutting an estimated $622M.
  • Citadel Advisors fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $597M.
  • Citadel Advisors's ten largest holdings make up 29% of its $481B portfolio in Q3 2021.
  • Citadel Advisors opened 1,884 new positions and closed 1,724 in Q3 2021.
  • Citadel Advisors's portfolio value rose 7.8% quarter-over-quarter to $481B.

Based on Citadel Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.